Anordrin compositions and methods for treating diseases
US10231978B2 · kind B2 · utility
9Cited by
1References
14Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 30, 2015 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | May 9, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for treating cancer, reducing side effects, and reducing postmenopausal symptoms comprising anordrin or analog thereof (such as anordrin) alone or in combination with at least one other agent selected from the group consisting of tamoxifen, raloxifene or functional equivalent thereof, and an aromatase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.